These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38927590)

  • 61. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene.
    Negri G; Milani D; Colapietro P; Forzano F; Della Monica M; Rusconi D; Consonni L; Caffi LG; Finelli P; Scarano G; Magnani C; Selicorni A; Spena S; Larizza L; Gervasini C
    Clin Genet; 2015 Feb; 87(2):148-54. PubMed ID: 24476420
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rubinstein-Taybi syndrome: clinical and molecular overview.
    Roelfsema JH; Peters DJ
    Expert Rev Mol Med; 2007 Aug; 9(23):1-16. PubMed ID: 17942008
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rubinstein-Taybi syndrome: New neuroradiological and neuropsychiatric insights from a multidisciplinary approach.
    Ajmone PF; Avignone S; Gervasini C; Giacobbe A; Monti F; Costantino A; Esposito S; Marchisio P; Triulzi F; Milani D
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):406-415. PubMed ID: 29637745
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.
    Bartsch O; Schmidt S; Richter M; Morlot S; Seemanová E; Wiebe G; Rasi S
    Hum Genet; 2005 Sep; 117(5):485-93. PubMed ID: 16021471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genotype-phenotype analysis of ocular findings in Rubinstein-Taybi syndrome - A case report and review of literature.
    Jin E; Le H; Jewell A; Couser NL
    Ophthalmic Genet; 2024 Feb; 45(1):51-58. PubMed ID: 37017262
    [TBL] [Abstract][Full Text] [Related]  

  • 66. iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.
    Alari V; Russo S; Terragni B; Ajmone PF; Sironi A; Catusi I; Calzari L; Concolino D; Marotta R; Milani D; Giardino D; Mantegazza M; Gervasini C; Finelli P; Larizza L
    Stem Cell Res; 2018 Jul; 30():130-140. PubMed ID: 29883886
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.
    Rusconi D; Negri G; Colapietro P; Picinelli C; Milani D; Spena S; Magnani C; Silengo MC; Sorasio L; Curtisova V; Cavaliere ML; Prontera P; Stangoni G; Ferrero GB; Biamino E; Fischetto R; Piccione M; Gasparini P; Salviati L; Selicorni A; Finelli P; Larizza L; Gervasini C
    Hum Genet; 2015 Jun; 134(6):613-26. PubMed ID: 25805166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.
    Tsai AC; Dossett CJ; Walton CS; Cramer AE; Eng PA; Nowakowska BA; Pursley AN; Stankiewicz P; Wiszniewska J; Cheung SW
    Eur J Hum Genet; 2011 Jan; 19(1):43-9. PubMed ID: 20717166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel mutation c.4003 G>C in the CREBBP gene in an adult female with Rubinstein-Taybi syndrome presenting with subtle dysmorphic features.
    Li C; Szybowska M
    Am J Med Genet A; 2010 Nov; 152A(11):2939-41. PubMed ID: 20949605
    [No Abstract]   [Full Text] [Related]  

  • 70. Rubinstein-Taybi syndrome (CREBBP, EP300).
    van Belzen M; Bartsch O; Lacombe D; Peters DJ; Hennekam RC
    Eur J Hum Genet; 2011 Jan; 19(1):preceeding 118-20. PubMed ID: 20664634
    [No Abstract]   [Full Text] [Related]  

  • 71. Rubinstein-Taybi syndrome: a rare case report of a female child emphasizing physiotherapy on gross motor function.
    Kovela RK; Qureshi MI; Manakandathil A; Sinha MK; Dinesh N; Harjpal P
    Pan Afr Med J; 2021; 40():85. PubMed ID: 34909074
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein-Taybi syndrome.
    Wincent J; Luthman A; van Belzen M; van der Lans C; Albert J; Nordgren A; Anderlid BM
    Mol Genet Genomic Med; 2016 Jan; 4(1):39-45. PubMed ID: 26788536
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma.
    Merk DJ; Ohli J; Merk ND; Thatikonda V; Morrissy S; Schoof M; Schmid SN; Harrison L; Filser S; Ahlfeld J; Erkek S; Raithatha K; Andreska T; Weißhaar M; Launspach M; Neumann JE; Shakarami M; Plenker D; Marra MA; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJM; Lutz B; Ertl-Wagner B; Rossi A; Wagener R; Siebert R; Jung A; Eberhart CG; Lach B; Sendtner M; Pfister SM; Taylor MD; Chavez L; Kool M; Schüller U
    Dev Cell; 2018 Mar; 44(6):709-724.e6. PubMed ID: 29551561
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tissue-specific mosaicism in a patient with Rubinstein-Taybi syndrome and CREBBP exon 1 duplication.
    Gucev ZS; Tasic VB; Saveski A; Polenakovic MH; Laban NB; Zechner U; Bartsch O
    Clin Dysmorphol; 2019 Jul; 28(3):142-144. PubMed ID: 30921089
    [No Abstract]   [Full Text] [Related]  

  • 75. Two adults with Rubinstein-Taybi syndrome with mild mental retardation, glaucoma, normal growth and skull circumference, and camptodactyly of third fingers.
    Wieczorek D; Bartsch O; Lechno S; Kohlhase J; Peters DJ; Dauwerse H; Gillessen-Kaesbach G; Hennekam RC; Passarge E
    Am J Med Genet A; 2009 Dec; 149A(12):2849-54. PubMed ID: 19938080
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.
    Petrij F; Dauwerse HG; Blough RI; Giles RH; van der Smagt JJ; Wallerstein R; Maaswinkel-Mooy PD; van Karnebeek CD; van Ommen GJ; van Haeringen A; Rubinstein JH; Saal HM; Hennekam RC; Peters DJ; Breuning MH
    J Med Genet; 2000 Mar; 37(3):168-76. PubMed ID: 10699051
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rubinstein-Taybi syndrome with multiple pilomatricomas: The first case diagnosed by CREBBP mutation analysis.
    Rokunohe D; Nakano H; Akasaka E; Toyomaki Y; Sawamura D
    J Dermatol Sci; 2016 Sep; 83(3):240-2. PubMed ID: 27342041
    [No Abstract]   [Full Text] [Related]  

  • 78. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes.
    Di Fede E; Massa V; Augello B; Squeo G; Scarano E; Perri AM; Fischetto R; Causio FA; Zampino G; Piccione M; Curridori E; Mazza T; Castellana S; Larizza L; Ghelma F; Colombo EA; Gandini MC; Castori M; Merla G; Milani D; Gervasini C
    Eur J Hum Genet; 2021 Jan; 29(1):88-98. PubMed ID: 32641752
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel heterozygous variants in the EP300 gene cause Rubinstein-Taybi syndrome 2: Reports from two Chinese children.
    Du C; Li Z; Zou B; Li X; Chen F; Liang Y; Luo X; Shu S
    Mol Genet Genomic Med; 2023 Sep; 11(9):e2192. PubMed ID: 37162176
    [TBL] [Abstract][Full Text] [Related]  

  • 80. EP300-related Rubinstein-Taybi syndrome: Highlighted rare phenotypic findings and a genotype-phenotype meta-analysis of 74 patients.
    Cohen JL; Schrier Vergano SA; Mazzola S; Strong A; Keena B; McDougall C; Ritter A; Li D; Bedoukian EC; Burke LW; Hoffman A; Zurcher V; Krantz ID; Izumi K; Bhoj E; Zackai EH; Deardorff MA
    Am J Med Genet A; 2020 Dec; 182(12):2926-2938. PubMed ID: 33043588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.